AU Patent

AU2008304439A1 — (s)-ethyl 2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluorethoxy)pyrimidin-4-yl)phenyl)propanoate

Assigned to Tersera Therapeutics LLC · Expires 2009-04-02 · 17y expired

What this patent protects

Patent listed against telotristat-etiprate.

Drugs covered by this patent

telotristat-etiprate (TELOTRISTAT ETIPRATE)

Patent Metadata

Patent number: AU2008304439A1
Jurisdiction: AU
Classification: —
Expires: 2009-04-02
Drug substance claim: No
Drug product claim: No
Assignee: Tersera Therapeutics LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.